No Data
No Data
We Think MediciNova (NASDAQ:MNOV) Can Afford To Drive Business Growth
MediciNova To Participate in D. Boral's Capital Global Conference on May 14, 2025
Reported Earlier, MediciNova Announces First Enrollment In NIH-Supported EAP Trial To Assess MN-166 In Advanced ALS Patients
Express News | D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target
MediciNova: Supplementary explanation of financial results for the fiscal year ending 2024/12
MediciNova: Summary of Financial Results for the Fiscal Year Ending 2024/12 [American GAAP] (Consolidated)